Newron Pharmaceuticals
NWRN.SW
#8290
Rank
A$0.27 B
Marketcap
$14.54
Share price
-2.15%
Change (1 day)
94.84%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -A$28.34 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are A$10.01 Million. In 2023 the company made an earning of -A$28.34 Million, an increase over its 2022 earnings that were of -A$29.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-A$28.34 Million-4.45%
2022-A$29.66 Million11.19%
2021-A$26.68 Million-30.14%
2020-A$38.19 Million6.84%
2019-A$35.74 Million31.45%
2018-A$27.19 Million170.13%
2017-A$10.07 Million-60.23%
2016-A$25.31 Million-41.46%
2015-A$43.23 Million109.46%
2014-A$20.64 Million22.43%
2013-A$16.86 Million222.49%
2012-A$5.23 Million-60.49%
2011-A$13.23 Million-71%
2010-A$45.62 Million-17.37%
2009-A$55.21 Million52.58%
2008-A$36.19 Million41.24%
2007-A$25.62 Million-25.19%
2006-A$34.25 Million22.45%
2005-A$27.97 Million